Finance

Lists
Why is BOI up 2.05%?
Dive Deeper
BOI:EPA
Boiron SA
€19.90
+2.05%
(+0.40) 1D
ኖቬም 6, 5:35:11 ከሰዓት ጂ ኤም ቲ+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BOI...
Open
€19.90
High
€19.90
Low
€19.20
Mkt. cap
350.39 ሚ
Avg. vol.
4.95 ሺ
Volume
4.25 ሺ
P/E ratio
13.19
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55 ሚ
No. of employees
3 ሺ
Open
€19.90
High
€19.90
Low
€19.20
Mkt. cap
350.39 ሚ
Avg. vol.
4.95 ሺ
Volume
4.25 ሺ
P/E ratio
13.19
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55 ሚ
No. of employees
3 ሺ
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
ከ27 ደቂቃዎች በፊት
3 Internet Giants to Hold for the Next 10 Years
Bloomberg.com
Bloomberg.com
·
ከ16 ሰዓቶች በፊት
Anatomy of a Selloff: Sudden Chain Reaction Rattles Wall Street
Fox Business
Fox Business
·
ከ13 ሰዓቶች በፊት
Nasdaq rallies as chip stocks recover from brutal losses
Investor's Business Daily
Investor's Business Daily
·
ከ8 ሰዓቶች በፊት
Futures: Market Needs Repair; These Big Winners Are Broken
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2.62 ሺ
Founded7 ጁን 1932
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
127.73 ሚ
127.73 ሚ
120.16 ሚ
120.16 ሚ
Cost of goods sold
35.40 ሚ
35.40 ሚ
33.53 ሚ
33.53 ሚ
Cost of revenue
35.40 ሚ
35.40 ሚ
33.53 ሚ
33.53 ሚ
Research and development expenses
1.56 ሚ
1.56 ሚ
1.44 ሚ
1.44 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79.26 ሚ
79.26 ሚ
79.95 ሚ
79.95 ሚ
Operating expense
77.52 ሚ
77.52 ሚ
81.88 ሚ
81.88 ሚ
Total operating expenses
112.92 ሚ
112.92 ሚ
115.41 ሚ
115.41 ሚ
Operating income
14.81 ሚ
14.81 ሚ
4.76 ሚ
4.76 ሚ
Other non operating income
-1.13 ሚ
-1.13 ሚ
-2.29 ሚ
-2.29 ሚ
EBT including unusual items
13.82 ሚ
13.82 ሚ
4.02 ሚ
4.02 ሚ
EBT excluding unusual items
13.16 ሚ
13.16 ሚ
2.75 ሚ
2.75 ሚ
Income tax expense
3.18 ሚ
3.18 ሚ
1.56 ሚ
1.56 ሚ
Effective tax rate
22.99%
22.99%
38.90%
38.90%
Other operating expenses
-3.30 ሚ
-3.30 ሚ
488.00 ሺ
488.00 ሺ
Net income
10.64 ሚ
10.64 ሚ
2.46 ሚ
2.46 ሚ
Net profit margin
8.33%
8.33%
2.04%
2.04%
Earnings per share
-
-
-
-
Interest and investment income
653.00 ሺ
653.00 ሺ
636.50 ሺ
636.50 ሺ
Interest expense
-335.00 ሺ
-335.00 ሺ
-410.00 ሺ
-410.00 ሺ
Net interest expenses
318.00 ሺ
318.00 ሺ
226.50 ሺ
226.50 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
18.06 ሚ
18.06 ሚ
11.17 ሚ
11.17 ሚ
Gain or loss from assets sale
-446.00 ሺ
-446.00 ሺ
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች